Wada, S., Obika, S., Shibata, M., Yamamoto, T., Nakatani, M., Yamaoka, T., . . . Harada-Shiba, M. (2012). Development of a 2′,4′-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo. Nature Publishing Group.
シカゴスタイル引用形Wada, Shunsuke, Satoshi Obika, Masa-Aki Shibata, Tsuyoshi Yamamoto, Moeka Nakatani, Tetsuji Yamaoka, Hidetaka Torigoe, , Mariko Harada-Shiba. Development of a 2′,4′-BNA/LNA-based SiRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo. Nature Publishing Group, 2012.
MLA引用形式Wada, Shunsuke, et al. Development of a 2′,4′-BNA/LNA-based SiRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo. Nature Publishing Group, 2012.